drugset / Trial / NCT04312971

Norepinephrine Infusion During Cardiopulmonary Bypass

NCT04312971

RandomizedParallel-groupDouble-blindPrevention

Summary

The primary objective is to test the efficacy and safety of the accuracy of continuous intravenous infusion of norepinephrine during cardiopulmonary bypass (CPB) on the prevention of hyperlactatemia after cardiac surgery. "Efficacy" would be tested with measurement of the postoperative changes in lactic acid level over time from the baseline value before induction of general anesthesia. "safety" would be tested with observing the post-cardiotomy need for inotropic and vasopressor support, the incidence of postoperative acute kidney injury (AKI), changes in cardiac troponin level (CnTnI), and signs of ischemic splanchnic injury.

Timeline

Start
2020-05-06
Primary completion
2021-04-10
Completion
2021-09-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Norepinephrine Other / unclassified 40 ug/ml Intravenous

Indications

No indication recorded.